Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice

121Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Accumulation of the amyloid-β peptide (Aβ) in the brain is crucial for development of Alzheimer's disease. Expression of transforming growth factor-β1 (TGF-β1), an immunosuppressive cytokine, has been correlated in vivo with Aβ accumulation in transgenic mice and recently with Aβ clearance by activated microglia. Here, we demonstrate that TGF-β1 drives the production of Aβ40/42 by astrocytes leading to Aβ production in TGF-β1 transgenic mice. First, TGF-β1 induces the overexpression of the amyloid precursor protein (APP) in astrocytes but not in neurons, involving a highly conserved TGF-β1-responsive element in the 5′-untranslated region (+54/+74) of the APP promoter. Second, we demonstrated an increased release of soluble APP-β which led to TGF-β1-induced Aβ generation in both murine and human astrocytes. These results demonstrate that TGF-β1 potentiates Aβ production in human astrocytes and may enhance the formation of plaques burden in the brain of Alzheimer's disease patients.

Cite

CITATION STYLE

APA

Lesné, S., Docagne, F., Gabriel, C., Liot, G., Lahiri, D. K., Buée, L., … Vivien, D. (2003). Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice. Journal of Biological Chemistry, 278(20), 18408–18418. https://doi.org/10.1074/jbc.M300819200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free